| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 765320 | 89682 | TAMSULOSINA PENSA PHARMA 0,4 MG CAPSULAS DURAS DE LIBERACION MODIFICADA EFG | TAMSULOSINA PENSA PHARMA 0,4 MG CAPSULAS DURAS DE LIBERACION MODIFICADA EFG, 30 cápsulas | 0,4 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89682/89682_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89682/89682_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40831 | TOWA PHARMACEUTICAL S.A. | 2024-07-04 | 1 | 1 | 1 | 2024-07-05 | 2024-07-04 | 1 | 2025-06-12 | View Edit Delete | ||||||||||||
| 767041 | R7164IP1 | OMNIC 0,4 MG CAPSULAS DE LIBERACION MODIFICADA | OMNIC 0,4 MG CAPSULAS DE LIBERACION MODIFICADA, 30 cápsulas | 0,4 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/R7164IP1/R7164IP1_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 43818 | MELYFARMA S.L. | 2025-02-26 | 1 | 1 | 1 | 2025-02-27 | 2025-02-26 | 1 | 2025-07-12 | View Edit Delete | ||||||||||||
| 767089 | 67308 | TAMSULOSINA CINFA 0,4 mg CAPSULAS DURAS DE LIBERACION MODIFICADA EFG | TAMSULOSINA CINFA 0,4 mg CAPSULAS DURAS DE LIBERACION MODIFICADA EFG, 30 cápsulas (PVC/PVDC/AL) | 0,4 mg | 5 | 30 | 43 | 30 cápsulas (PVC/PVDC/AL) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67308/67308_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67308/67308_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2005-12-01 | 1 | 1 | 1 | 2005-12-01 | 2025-02-27 | 1 | 2025-10-13 | View Edit Delete | ||||||||||||
| 769400 | 11429IP3 | OMNIC OCAS 0,4 mg COMPRIMIDOS DE LIBERACION PROLONGADA RECUBIERTOS CON PELICULA | OMNIC OCAS 0,4 mg COMPRIMIDOS DE LIBERACION PROLONGADA RECUBIERTOS CON PELICULA, 30 comprimidos | 0,4 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/11429IP3/11429IP3_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 43818 | EUROMED PHARMA SPAIN S.L. | 2025-12-05 | 1 | 1 | 1 | 2025-12-06 | 2025-12-05 | 1 | 2026-02-12 | View Edit Delete | ||||||||||||
| 770110 | 6775201401IP1 | OMNIC OCAS 0,4 MG COMPRIMIDOS DE LIBERACION PROLONGADA RECUBIERTOS CON PELICULA | OMNIC OCAS 0,4 MG COMPRIMIDOS DE LIBERACION PROLONGADA RECUBIERTOS CON PELICULA, 30 comprimidos | 0,4 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/6775201401IP1/6775201401IP1_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 13990 | DIFARMED S.L.U. | 2026-03-09 | 1 | 1 | 1 | 2026-03-10 | 2026-03-09 | 0 | 2026-05-13 | View Edit Delete | ||||||||||||
| 768526 | 90569 | TAMSULOSINA VIATRIS PHARMACEUTICALS 0,4 MG CAPSULAS DURAS DE LIBERACION MODIFICADA EFG | TAMSULOSINA VIATRIS PHARMACEUTICALS 0,4 MG CAPSULAS DURAS DE LIBERACION MODIFICADA EFG, 30 cápsulas | 0,4 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90569/90569_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90569/90569_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 44524 | VIATRIS PHARMACEUTICALS S.L. | 2025-10-14 | 1 | 1 | 1 | 2025-10-14 | 2025-10-14 | 1 | 2026-03-13 | View Edit Delete | ||||||||||||
| 703094 | 78928 | VOLUTSA 6 MG/0,4 MG COMPRIMIDOS DE LIBERACION MODIFICADA | VOLUTSA 6 MG/0,4 MG COMPRIMIDOS DE LIBERACION MODIFICADA, 30 comprimidos | 0,4 mg/6 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/78928/78928_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/78928/78928_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40569 | LABORATORIOS FARMACEUTICOS ROVI S.A. | 2014-07-22 | 1 | 1 | 1 | 2014-07-22 | 2014-07-22 | 1 | 2014-12-12 | View Edit Delete | ||||||||||||
| 701917 | 78607 | VESOMNI 6 MG/0,4 MG COMPRIMIDOS DE LIBERACION MODIFICADA | VESOMNI 6 MG/0,4 MG COMPRIMIDOS DE LIBERACION MODIFICADA , 30 comprimidos | 0,4 mg/6 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/78607/78607_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/78607/78607_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40569 | ASTELLAS PHARMA S.A. | 2014-03-28 | 1 | 1 | 1 | 2014-03-28 | 2014-03-28 | 1 | 2014-12-12 | View Edit Delete | ||||||||||||
| 758764 | 88217 | BLOBAX 6 MG/0,4 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG | BLOBAX 6 MG/0,4 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG, 30 comprimidos | 0,4 mg/6 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88217/88217_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88217/88217_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12947 | TECNIMEDE ESPAÑA INDUSTRIA FARMACEUTICA S.A. | 2022-10-21 | 1 | 1 | 1 | 2022-10-22 | 2022-10-21 | 0 | 2023-04-13 | View Edit Delete | ||||||||||||
| 758765 | 88218 | VESOLTA 6 MG/0,4 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG | VESOLTA 6 MG/0,4 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG, 30 comprimidos | 0,4 mg/6 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88218/88218_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88218/88218_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2022-10-19 | 1 | 1 | 1 | 2022-10-20 | 2022-10-19 | 0 | 2023-04-14 | View Edit Delete | ||||||||||||
| 762960 | 88918 | BITAMSOL 6 MG/0,4 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG | BITAMSOL 6 MG/0,4 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG, 30 comprimidos | 0,4 mg/6 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88918/88918_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88918/88918_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11636 | LABORATORIOS Q PHARMA S.L. | 2023-06-20 | 1 | 1 | 1 | 2023-06-21 | 2023-06-20 | 1 | 2024-02-06 | View Edit Delete | ||||||||||||
| 762368 | 88710 | SOLIFENACINA/TAMSULOSINA NORMON 6 MG/0,4 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG | SOLIFENACINA/TAMSULOSINA NORMON 6 MG/0,4 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG, 30 comprimidos | 0,4 mg/6 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88710/88710_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88710/88710_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2023-03-07 | 1 | 1 | 1 | 2023-03-08 | 2023-03-07 | 0 | 2023-04-13 | View Edit Delete | ||||||||||||
| 762392 | 88721 | SOLIFENACINA/TAMSULOSINA TEVA 6 MG/0,4 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG | SOLIFENACINA/TAMSULOSINA TEVA 6 MG/0,4 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG, 30 comprimidos | 0,4 mg/6 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88721/88721_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88721/88721_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16041 | TEVA PHARMA S.L.U. | 2023-03-09 | 1 | 1 | 1 | 2023-03-10 | 2023-03-09 | 0 | 2023-04-14 | View Edit Delete | ||||||||||||
| 762902 | 88894 | SOLIFENACINA/TAMSULOSINA STADAPHARMA 6 MG/0,4 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG | SOLIFENACINA/TAMSULOSINA STADAPHARMA 6 MG/0,4 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG, 30 comprimidos | 0,4 mg/6 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88894/88894_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88894/88894_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | LABORATORIO STADA S.L. | 2023-06-08 | 1 | 1 | 1 | 2023-06-09 | 2023-06-08 | 1 | 2024-04-12 | View Edit Delete | ||||||||||||
| 761524 | 88509 | SOLIFENACINA/TAMSULOSINA CINFAMED 6 MG/0.4 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG | SOLIFENACINA/TAMSULOSINA CINFAMED 6 MG/0.4 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG, 30 comprimidos | 0,4 mg/6 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88509/88509_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88509/88509_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2023-01-13 | 1 | 1 | 1 | 2023-01-14 | 2023-01-13 | 0 | 2023-05-08 | View Edit Delete | ||||||||||||
| 762956 | 88915 | SOLIFENACINA /TAMSULOSINA AUROVITAS 6 MG/0,4 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG | SOLIFENACINA /TAMSULOSINA AUROVITAS 6 MG/0,4 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG, 30 comprimidos | 0,4 mg/6 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88915/88915_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88915/88915_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16109 | AUROVITAS SPAIN, S.A.U. | 2023-06-19 | 1 | 1 | 1 | 2023-06-20 | 2023-06-19 | 1 | 2024-03-13 | View Edit Delete | ||||||||||||
| 762303 | 88683 | SOLIFENACINA/TAMSULOSINA PENSA 6 MG/0,4 MG COMPRIMIDOS DE LIBERACIÓN MODIFICADA EFG | SOLIFENACINA/TAMSULOSINA PENSA 6 MG/0,4 MG COMPRIMIDOS DE LIBERACIÓN MODIFICADA EFG, 30 comprimidos | 0,4 mg/6 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88683/88683_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88683/88683_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40831 | TOWA PHARMACEUTICAL S.A. | 2023-02-22 | 1 | 1 | 1 | 2023-02-23 | 2023-02-22 | 1 | 2023-05-09 | View Edit Delete | ||||||||||||
| 763714 | 89139 | SOLIFENACINA/TAMSULOSINA ALTER 6 MG/0,4 MG COMPRIMIDOS DE LIBERACIÓN MODIFICADA EFG | SOLIFENACINA/TAMSULOSINA ALTER 6 MG/0,4 MG COMPRIMIDOS DE LIBERACIÓN MODIFICADA EFG, 30 comprimidos | 0,4 mg/6 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89139/89139_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89139/89139_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 137 | LABORATORIOS ALTER S.A. | 2023-11-08 | 1 | 1 | 1 | 2023-11-09 | 2023-11-08 | 1 | 2024-06-07 | View Edit Delete | ||||||||||||
| 763715 | 89140 | DAITAL 6 MG/0,4 MG COMPRIMIDOS DE LIBERACIÓN MODIFICADA EFG | DAITAL 6 MG/0,4 MG COMPRIMIDOS DE LIBERACIÓN MODIFICADA EFG, 30 comprimidos | 0,4 mg/6 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89140/89140_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89140/89140_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 137 | LABORATORIOS ALTER S.A. | 2023-11-08 | 1 | 1 | 1 | 2023-11-09 | 2023-11-08 | 1 | 2024-04-11 | View Edit Delete | ||||||||||||
| 763415 | 89055 | SOLIFENACINA/TAMSULOSINA VIATRIS 6 MG/0,4 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG | SOLIFENACINA/TAMSULOSINA VIATRIS 6 MG/0,4 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG, 30 comprimidos | 0,4 mg/6 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89055/89055_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89055/89055_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38105 | VIATRIS PHARMACEUTICALS S.L.U. | 2023-10-04 | 1 | 1 | 1 | 2023-10-04 | 2023-10-04 | 1 | 2024-04-12 | View Edit Delete |
Page 20 of 1036, showing 20 records out of 20715 total, starting on record 381, ending on 400